Takahashi M - Search Results

1

Efficacy of vonoprazan-based second-line Helicobacter pylori eradication therapy in patients for whom vonoprazan-based ﬁrst-line treatment failed.

Katayama Y, Toyoda K, Kusano Y, Suda T, Adachi S, Terauchi I, Oka S, Takahashi M, Tamano M. Katayama Y, et al. Among authors: takahashi m. Gut. 2017 Apr;66(4):752-753. doi: 10.1136/gutjnl-2016-312028. Epub 2016 May 17. Gut. 2017. PMID: 27196582 No abstract available.

2

[Complication of peptic ulcer disease].

Kuwayama H, Takahashi M, Takata H, Oka S, Anzai T, Matsukawa Y, Hirosawa M, Shiba T. Kuwayama H, et al. Among authors: takahashi m. Nihon Rinsho. 2002 Feb;60 Suppl 2:357-61. Nihon Rinsho. 2002. PMID: 11979807 Review. Japanese. No abstract available.

3

[Continuation of acid suppression therapy after H. pylori eradication].

Takahashi M, Kuwayama H. Takahashi M, et al. Nihon Rinsho. 2002 Feb;60 Suppl 2:531-5. Nihon Rinsho. 2002. PMID: 11979841 Review. Japanese. No abstract available.

4

[PPI-test].

Takahashi M, Katayama Y, Suzuki K, Tajima A, Oka S, Koizumi K, Ichimura H, Kuwayama H. Takahashi M, et al. Nihon Rinsho. 2007 May;65(5):852-63. Nihon Rinsho. 2007. PMID: 17511224 Review. Japanese.

5

Helicobacter pylori causes runx3 gene methylation and its loss of expression in gastric epithelial cells, which is mediated by nitric oxide produced by macrophages.

Katayama Y, Takahashi M, Kuwayama H. Katayama Y, et al. Among authors: takahashi m. Biochem Biophys Res Commun. 2009 Oct 23;388(3):496-500. doi: 10.1016/j.bbrc.2009.08.003. Epub 2009 Aug 5. Biochem Biophys Res Commun. 2009. PMID: 19665002

6

Reversal of the tolerance phenomenon by the intermittent administration of a histamine H2-receptor antagonist.

Takahashi M, Katayama Y. Takahashi M, et al. J Gastroenterol Hepatol. 2010 Sep;25(9):1493-7. doi: 10.1111/j.1440-1746.2010.06308.x. J Gastroenterol Hepatol. 2010. PMID: 20796145 Clinical Trial.

7

COVID-19 pandemic and exacerbation of ulcerative colitis.

Suda T, Takahashi M, Katayama Y, Tamano M. Suda T, et al. Among authors: takahashi m. World J Clin Cases. 2021 Dec 26;9(36):11220-11227. doi: 10.12998/wjcc.v9.i36.11220. World J Clin Cases. 2021. PMID: 35071552 Free PMC article.

8

Progress of ulcerative colitis patients during the COVID-19 pandemic.

Suda T, Takahashi M, Katayama Y, Soga K, Kobori I, Kusano Y, Tamano M. Suda T, et al. Among authors: takahashi m. World J Clin Cases. 2023 Aug 16;11(23):5462-5467. doi: 10.12998/wjcc.v11.i23.5462. World J Clin Cases. 2023. PMID: 37637693 Free PMC article.

9

[Polaprezinc].

Kuwayama H, Takahashi M, Suzuki K, Suga M, Takata H, Ohara T, Koizumi K, Kiriyama Y. Kuwayama H, et al. Among authors: takahashi m. Nihon Rinsho. 2002 Feb;60 Suppl 2:717-20. Nihon Rinsho. 2002. PMID: 11979877 Review. Japanese. No abstract available.

10

Does colonoscopy by a skilled endoscopist cause any adverse effects in quiescent ulcerative colitis patients? a case-control study.

Takahashi M, Katayama Y, Suzuki K, Koizumi K, Nishida K, Kuwayama H. Takahashi M, et al. J Clin Gastroenterol. 2010 Nov-Dec;44(10):720-2. doi: 10.1097/MCG.0b013e3181d7b1be. J Clin Gastroenterol. 2010. PMID: 20421809 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,242 results

Search Page

Filters